{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:15:03Z","timestamp":1787026503473,"version":"build-2736575974"},"reference-count":110,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00602","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T04:54:59Z","timestamp":1481777699000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["Plague Vaccine Development: Current Research and Future Trends"],"prefix":"10.3389","volume":"7","author":[{"given":"Shailendra Kumar","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmil","family":"Tuteja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis \u2013 etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev.ento.50.071803.130337","article-title":"Natural history of plague: perspectives from more than a century of research","volume":"50","author":"Gage","year":"2005","journal-title":"Annu Rev Entomol"},{"key":"B3","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1128\/JCM.35.11.2826-2833.1997","article-title":"Recent emergence of new variants of Yersinia pestis in Madagascar","volume":"35","author":"Guiyoule","year":"1997","journal-title":"J Clin Microbiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1099\/00221287-148-6-1687","article-title":"Genome plasticity in Yersinia pestis","volume":"148","author":"Radnedge","year":"2002","journal-title":"Microbiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1056\/NEJM199709043371004","article-title":"Multidrug resistance in Yersinia pestis mediated by a transferable plasmid","volume":"337","author":"Galimand","year":"1997","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3201\/eid0701.700043","article-title":"Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis","volume":"7","author":"Guiyoule","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1365-2958.2002.03159.x","article-title":"High-frequency conjugative transfer of antibiotic resistance genes to Yersinia pestis in the flea midgut","volume":"46","author":"Hinnebusch","year":"2002","journal-title":"Mol Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1371\/journal.pone.0000309","article-title":"Multiple antimicrobial resistance in plague: an emerging public health risk","volume":"2","author":"Welch","year":"2007","journal-title":"PLoS One"},{"key":"B9","volume-title":"Biohazard","author":"Alibek","year":"1999"},{"key":"B10","first-page":"37","article-title":"Bioterrorism and infectious agents: a new dilemma for the 21st century","volume-title":"Plague as a Biological Weapon","author":"Dennis","year":"2005"},{"key":"B11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/10408410500496896","article-title":"The anti-plague system and the Soviet biological warfare program","volume":"32","author":"Zilinskas","year":"2006","journal-title":"Crit Rev Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1586\/erv.09.129","article-title":"Prospects for new plague vaccines","volume":"8","author":"Feodorova","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"B13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/vbz.2011.0748","article-title":"Phenotypical characterization of Mongolian Yersinia pestis strains","volume":"12","author":"Kiefer","year":"2012","journal-title":"Vector Borne Zoonotic Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10549","article-title":"A draft genome of Yersinia pestis from victims of the black death","volume":"478","author":"Bos","year":"2011","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"788","DOI":"10.4269\/ajtmh.13-0191","article-title":"Plague gives surprises in the first decade of the 21st century in the United States and worldwide","volume":"89","author":"Butler","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"B16","volume-title":"Plague","author":"Pollitzer","year":"1954"},{"key":"B17","first-page":"631","article-title":"Immunity in plague infection: results of 30 years of work with the Pasteurella pestis EV strain (Girard and Robic)","volume":"52","author":"Girard","year":"1963","journal-title":"Biol Med (Paris)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"Russell","year":"1995","journal-title":"Vaccine"},{"key":"B19","first-page":"653","article-title":"Effectiveness of live or killed plague vaccines in man","volume":"42","author":"Meyer","year":"1970","journal-title":"Bull World Health Organ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1093\/infdis\/129.Supplement_1.S13","article-title":"Plague immunization. I. Past and present trends","volume":"129","author":"Meyer","year":"1974","journal-title":"J Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/infdis\/129.Supplement_1.S37","article-title":"Plague immunization. V. Indirect evidence for the efficacy of plague vaccine","volume":"129","author":"Cavanaugh","year":"1974","journal-title":"J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1001\/jama.202.4.365","article-title":"Pneumonic plague in an untreated plague-vaccinated individual","volume":"202","author":"Cohen","year":"1967","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"B24","volume-title":"Live Anti-Plague Vaccine","author":"Korobkova","year":"1956"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1038\/emi.2014.82","article-title":"Russian vaccines against especially dangerous bacterial pathogens","volume":"12","author":"Feodorova","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"B26","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/IAI.64.6.2180-2187.1996","article-title":"Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge","volume":"64","author":"Andrews","year":"1996","journal-title":"Infect Immun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e3322","DOI":"10.1371\/journal.pntd.0003322","article-title":"HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model","volume":"8","author":"Batra","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B28","first-page":"325","article-title":"Construction of defined F1 negative mutants of virulent Yersinia pestis","volume":"13","author":"Worsham","year":"1995","journal-title":"Contrib Microbiol Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1128\/JCM.00064-11","article-title":"Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic plague and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks","volume":"5","author":"Sha","year":"2011","journal-title":"J Clin Microbiol"},{"key":"B30","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/IAI.64.11.4580-4585.1996","article-title":"Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and negative strains of Y. pestis","volume":"64","author":"Anderson","year":"1996","journal-title":"Infect Immun"},{"key":"B31","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.1998.58.793","article-title":"Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice","volume":"58","author":"Anderson","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"B32","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/IAI.62.10.4192-4201.1994","article-title":"Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide","volume":"10","author":"Motin","year":"1994","journal-title":"Infect Immun"},{"key":"B33","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1128\/IAI.63.8.3021-3029.1995","article-title":"Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization","volume":"8","author":"Nakajima","year":"1995","journal-title":"Infect Immun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0264-410X(96)00151-X","article-title":"Local and systemic immune response to a microencapsulated subunit vaccine for plague","volume":"14","author":"Williamson","year":"1996","journal-title":"Vaccine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0264-410X(00)00108-0","article-title":"Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains","volume":"19","author":"Jones","year":"2000","journal-title":"Vaccine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1003495","DOI":"10.1371\/journal.ppat.1003495","article-title":"Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines","volume":"9","author":"Tao","year":"2013","journal-title":"PLoS Pathog"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1128\/CVI.00333-09","article-title":"Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague","volume":"12","author":"Eisele","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.vaccine.2009.11.076","article-title":"Amino acid residues 196-225 of LcrV represent a plague protective epitope","volume":"7","author":"Quenee","year":"2010","journal-title":"Vaccine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1128\/IAI.00699-08","article-title":"Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague","volume":"76","author":"Cornelius","year":"2008","journal-title":"Infect Immun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1016\/j.vaccine.2011.04.084","article-title":"Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague","volume":"29","author":"Williamson","year":"2011","journal-title":"Vaccine"},{"key":"B44","first-page":"13","volume-title":"Non-Human Primates as a Model for Pneumonic Plague; Animal Models and Correlates of Protection for Plague Vaccines Workshop","author":"Pitt","year":"2004"},{"key":"B45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune defense against pneumonic plague","volume":"225","author":"Smiley","year":"2008","journal-title":"Immunol Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates","volume":"16","author":"Mizel","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1365-3083.2010.02456.x","article-title":"Comparison of immunological responses of plague vaccines F11rV270 and EV76 in Chinese-origin rhesus macaque, Macaca mulatta","volume":"72","author":"Qiu","year":"2010","journal-title":"Scand J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4049\/jimmunol.181.1.109","article-title":"An age-old paradigm challenged: old baboons generate vigorous humoral immune responses to LcrV, a plague antigen","volume":"181","author":"Stacy","year":"2008","journal-title":"J Immunol"},{"key":"B49","first-page":"176","article-title":"Plague vaccines","volume-title":"Vaccines Against Bacterial Biothreat Pathogens","author":"Feodorova","year":"2011"},{"key":"B50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0882-4010(92)90050-X","article-title":"The difference in the lcrV sequences between Yersinia pestis and Yersinia pseudotuberculosis and its application for characterization of Y. pseudotuberculosis strains","volume":"12","author":"Motin","year":"1992","journal-title":"Microb Pathog"},{"key":"B51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.meegid.2009.10.003","article-title":"Amino acid and structural variability of Yersinia pestis LcrV protein","volume":"10","author":"Anisimov","year":"2010","journal-title":"Infect Genet Evol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2180-5-38","article-title":"Immunization of mice with YscF provides protection from Yersinia pestis infections","volume":"5","author":"Matson","year":"2005","journal-title":"BMC Microbiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pep.2005.02.016","article-title":"Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague","volume":"1","author":"Swietnicki","year":"2005","journal-title":"Protein Expr Purif"},{"key":"B54","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1128\/CVI.00597-12","article-title":"Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine","volume":"2","author":"Erova","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1126\/science.8493576","article-title":"Protection against vaginal SIV transmission with microencapsulated vaccine","volume":"260","author":"Marx","year":"1993","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/1044-579X(95)90007-1","article-title":"Selection of potent immunological adjuvants for vaccine construction","volume":"6","author":"McElrath","year":"1995","journal-title":"Semin Cancer Biol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1073\/pnas.92.5.1644","article-title":"Mutants of Escherichia coli heat-labile toxin lacking ADP ribosyl-transferase activity act as non-toxic mucosal adjuvants","volume":"92","author":"Douce","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1016\/j.vaccine.2004.02.049","article-title":"Immunisation against plague by transcutaneous and intradermal application of subunit antigens","volume":"22","author":"Eyles","year":"2004","journal-title":"Vaccine"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"Honko","year":"2006","journal-title":"Infect Immun"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1016\/j.vaccine.2009.02.016","article-title":"CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague","volume":"27","author":"Amemiya","year":"2009","journal-title":"Vaccine"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1128\/IAI.00316-13","article-title":"Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection","volume":"81","author":"Hickey","year":"2013","journal-title":"Infect Immun"},{"key":"B62","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-3083.2009.02365.x","article-title":"Cell-mediated immune response and Th1\/Th2 cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis","volume":"71","author":"Gupta","year":"2010","journal-title":"Scand J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1016\/j.vaccine.2008.08.007","article-title":"Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine","volume":"26","author":"Airharta","year":"2008","journal-title":"Vaccine"},{"key":"B64","doi-asserted-by":"publisher","first-page":"5924","DOI":"10.1016\/j.vaccine.2010.06.020","article-title":"Protection against pneumonic plague following oral immunization with a non-replicating vaccine","volume":"28","author":"Jones","year":"2010","journal-title":"Vaccine"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.vaccine.2005.09.052","article-title":"Intranasal protollin\/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection","volume":"24","author":"Jones","year":"2006","journal-title":"Vaccine"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1016\/j.vaccine.2014.07.015","article-title":"Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant","volume":"32","author":"Dinc","year":"2014","journal-title":"Vaccine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3389\/fmicb.2016.01053","article-title":"A recombinant trivalent fusion protein F1-LcrV-HSP70(II) augments humoral and cellular immune responses and imparts full protection against Yersinia pestis","volume":"7","author":"Verma","year":"2016","journal-title":"Front Microbiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/j.vaccine.2009.03.011","article-title":"Small protective fragments of the Y. pestis V antigen","volume":"27","author":"Vernazza","year":"2009","journal-title":"Vaccine"},{"key":"B69","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1128\/IAI.00581-08","article-title":"A nasal interleukin-12 DNA vaccine co expressing Y. pestis F1-V fusion protein confers protection against pneumonic plague","volume":"76","author":"Yamanaka","year":"2008","journal-title":"Infect Immun"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"key":"B71","doi-asserted-by":"publisher","first-page":"6802","DOI":"10.1016\/j.vaccine.2010.12.062","article-title":"Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Y. pestis challenge","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.vaccine.2008.01.024","article-title":"Relative immunogenicity and protection potential of candidate Y. pestis antigens against lethal mucosal plague challenge in Balb\/C mice","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1086\/507644","article-title":"Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen","volume":"194","author":"Chiuchiolo","year":"2006","journal-title":"J Infect Dis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/hum.2009.148","article-title":"Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid","volume":"21","author":"Boyer","year":"2010","journal-title":"Hum Gene Ther"},{"key":"B75","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1128\/CVI.00150-16","article-title":"A replication-defective human type 5 adenovirus-based trivalent vaccine confers complete protection against plague in mice and nonhuman primates","volume":"7","author":"Sha","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.vaccine.2006.08.010","article-title":"An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge","volume":"25","author":"Palin","year":"2007","journal-title":"Vaccine"},{"key":"B77","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1016\/j.vaccine.2008.09.031","article-title":"Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection","volume":"26","author":"Chattopadhyay","year":"2008","journal-title":"Vaccine"},{"key":"B78","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1016\/j.vaccine.2010.06.054","article-title":"Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice","volume":"28","author":"Brewooa","year":"2010","journal-title":"Vaccine"},{"key":"B79","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1016\/j.vaccine.2010.09.039","article-title":"Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis","volume":"28","author":"Bhattacharya","year":"2010","journal-title":"Vaccine"},{"key":"B80","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nature05762","article-title":"Herpesvirus latency confers symbiotic protection from bacterial infection","volume":"447","author":"Barton","year":"2007","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/vbz.2009.0050","article-title":"Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus)","volume":"1","author":"Rocke","year":"2010","journal-title":"Vector Borne Zoonotic Dis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/vaccines2040772","article-title":"A recombinant raccoon poxvirus vaccine expressing both Yersinia pestis F1 and truncated V antigens protects animals against lethal plague","volume":"4","author":"Rocke","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"401","DOI":"10.7589\/2014-02-051","article-title":"Apparent field safety of a raccoon poxvirus-vectored plague vaccine in free-ranging prairie dogs (Cynomys spp.), Colorado, USA","volume":"2","author":"Tripp","year":"2015","journal-title":"J Wildl Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1006\/mpat.1997.0141","article-title":"Expression of an F1\/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague","volume":"23","author":"Leary","year":"1997","journal-title":"Microb Pathog"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1016\/S0264-410X(03)00112-9","article-title":"Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague","volume":"21","author":"Garmory","year":"2003","journal-title":"Vaccine"},{"key":"B86","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/IAI.65.5.1926-1930.1997","article-title":"Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague","volume":"65","author":"Titball","year":"1997","journal-title":"Infect Immun"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.4049\/jimmunol.178.2.1059","article-title":"Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague","volume":"178","author":"Yang","year":"2007","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/j.vaccine.2004.01.007","article-title":"Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice","volume":"22","author":"Morton","year":"2004","journal-title":"Vaccine"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.4049\/jimmunol.182.2.1211","article-title":"Mucosally delivered Salmonella Typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost","volume":"182","author":"Ramirez","year":"2009","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1128\/IAI.00005-10","article-title":"Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice","volume":"78","author":"Torres-Escobar","year":"2010","journal-title":"Infect Immun"},{"key":"B91","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3855\/jidc.2030","article-title":"Developing live vaccines against plague","volume":"5","author":"Sun","year":"2011","journal-title":"J Infect Dev Ctries"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1038\/emi.2012.34","article-title":"Plague vaccines: current developments and future perspectives","volume":"1","author":"Feodorova","year":"2012","journal-title":"Emerg Microbes Infect"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.vaccine.2008.12.022","article-title":"Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV","volume":"27","author":"Daniel","year":"2009","journal-title":"Vaccine"},{"key":"B94","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1016\/j.vaccine.2016.09.060","article-title":"Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis","volume":"47","author":"Daniel","year":"2016","journal-title":"Vaccine"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1128\/IAI.00034-08","article-title":"Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain","volume":"8","author":"Blisnick","year":"2008","journal-title":"Infect Immun"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e1528","DOI":"10.1371\/journal.pntd.0001528","article-title":"An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague","volume":"2","author":"Derbise","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e0004162","DOI":"10.1371\/journal.pntd.0004162","article-title":"Complete protection against pneumonic and bubonic plague after a single oral vaccination","volume":"10","author":"Derbise","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2016.03.030","article-title":"Oral vaccination against plague using Yersinia pseudotuberculosis","author":"Demeure","year":"2016","journal-title":"Chem Biol Interact"},{"key":"B99","first-page":"3","article-title":"Experience from a 30-year study of the stability of the properties of the plague vaccine strain EV in the USSR","volume":"6","author":"Saltykova","year":"1975","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.1016\/j.vaccine.2007.08.055","article-title":"Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs","volume":"25","author":"Feodorova","year":"2007","journal-title":"Vaccine"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/j.vaccine.2009.02.020","article-title":"Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens","volume":"27","author":"Feodorova","year":"2009","journal-title":"Vaccine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1073\/pnas.040565397","article-title":"Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation","volume":"97","author":"Poltorak","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in TLR4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"B104","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","article-title":"Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product","volume":"162","author":"Hoshino","year":"1999","journal-title":"J Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1172\/JCI8541","article-title":"Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide","volume":"105","author":"Lien","year":"2000","journal-title":"J Clin Invest"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/ni1386","article-title":"Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response","volume":"7","author":"Montminy","year":"2006","journal-title":"Nat Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1128\/IAI.01529-07","article-title":"Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague","volume":"76","author":"Sha","year":"2008","journal-title":"Infect Immun"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e7023","DOI":"10.1371\/journal.pone.0007023","article-title":"The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague","volume":"4","author":"Tidhar","year":"2009","journal-title":"PLoS One"},{"key":"B109","doi-asserted-by":"publisher","first-page":"13514","DOI":"10.1073\/pnas.0603456103","article-title":"RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague","volume":"103","author":"Cathelyn","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B110","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s1473-3099(11)70256-0","article-title":"Two is better than one","volume":"11","author":"Lu","year":"2011","journal-title":"Lancet Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00602\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T05:08:11Z","timestamp":1692594491000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00602\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,14]]},"references-count":110,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00602","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,14]]}}}